![Members of the In4Derm team. image (c) John Post](http://cdn-acquia.dundee.ac.uk/sites/default/files/styles/card/public/2020-09/In4Derm%20team.jpg?itok=l8CyRH1a)
Press release
A University of Dundee spinout company developing treatments for eczema, rheumatoid arthritis and other inflammatory conditions has completed its first round of private investment.
Press release
A University of Dundee spinout company developing treatments for eczema, rheumatoid arthritis and other inflammatory conditions has completed its first round of private investment.
News
The o2h human health EIS Fund has announced its intention to lead an investment into In4Derm.
Press release
The University of Dundee is to partner with global biopharmaceutical company Almirall to develop new treatments for severe skin diseases with high level of unmet medical need.
Press release
Researchers at the University of Dundee are looking to transform pharmaceutical and cosmetics testing with their spinout venture that offers an alternative for many experiments currently only performed in animals.
News
Joana Faria has been awarded a SULSA Early Career Research Prize for Development and Regulation.
News
The finalists for Converge 2020, Scotland’s leading academic company creation programme, have been announced with representation from the School included on the list with Dr Robyn Hickerson, Co-founder and Chief Scientific Officer of Ten Bio.
Press release
A research consortium featuring scientists from the University of Dundee have detailed how the genetic mutations that give rise to cancer are caused by a combination of DNA damage and inaccurate repair.
Press release
University of Dundee researchers have discovered a new neurodevelopmental disease caused by genetic mutations and helped explain why patients with these mutations suffer this condition.
News
Researchers in the School have discovered a new neurodevelopmental disease caused by genetic mutations and helped explain why patients with these mutations suffer this condition.
News
Sumitomo Dainippon Pharma and Exscientia announce that a phase I clinical study of DSP-1181, that was created using Artificial Intelligence (AI), has been initiated in Japan for the treatment of obsessive-compulsive disorder as an initial indication.
News
Professors Vicky Cowling and Tomo Tanaka were given Investigator Awards from Wellcome in the recent funding round.
News
Researchers in the Ciulli group report a first study describing the idea of a macrocyclic PROTAC. The research was published in the prestigious chemistry journal Angewandte Chemie.
Press release
The University of Dundee’s Professor David Horn has received a prestigious award in recognition of his contribution to global efforts to overcome the disease known as African sleeping sickness.
News
DEBRA is delighted to share that funding for a fourth year of the University of Dundee’s research into novel gene technology for treating Epidermolysis Bullosa (EB) has been agreed.
News
School of Life Sciences researcher Professor David Horn will receive a £2.1 million Investigator Award from Wellcome to decode gene expression mechanisms in trypanosomes, pathogenic protozoa that cause a range of human and animal diseases.
News
The University of Dundee has announced a new partnership with Eisai, one of the world’s leading research-based pharmaceutical companies.
Press release
A University of Dundee scientist has been awarded £1.4 million from Cancer Research UK to develop research that could bring a ceasefire to cellular warfare taking place within our DNA that can cause blood cancers such as Leukaemia.
Press release
The University of Dundee will share in a new €36.5million, European-wide grant for the European Lead Factory, a public-private partnership to transform drug targets into new medicines.
News
An Alessi lab PhD student working closely with the Ciulli lab has published an improved HaloPROTAC method to induce post–translational knockdown of endogenous proteins.
News
Researchers at the Centre for Gene Regulation and Expression have discovered that PI3KCA oncogene changes how cells require their protein contents to be made.